Cizzle Bio will attend the 2026 ASCO Quality Care Symposium in Boston and online, joining oncology leaders focused on safer, more efficient and patient-centered cancer care.

Cizzle Bio will attend the 2026 AVBCC Summit at the New York Athletic Club, October 7–9. The invitation-only forum brings oncology leaders together to discuss value-based cancer care, health policy, reimbursement, practice management, specialty pharmacy, and patient access.

Cizzle Bio attends GCRIS 2026 in New York, highlighting Scientific Advisor Dr. Steven Rosen’s panel participation and the expertise guiding its CIZ1B and broader biomarker strategy.

Cizzle Bio will attend the AACR Conference on Pancreatic Cancer in San Diego, September 25–28, 2026. The scientific meeting will explore early detection, precision oncology, KRAS-targeted therapies, immunotherapy, AI, multi-omics, tumor biology, and translational research.

Cizzle Bio will attend the Oracle Health and Life Sciences Summit 2026 at Disney’s Coronado Springs Resort in Orlando. The summit brings healthcare and life sciences leaders together to explore AI, trusted data, clinical development, real-world evidence, and patient-centered innovation.

Cizzle Bio will attend the TxSCO 2026 Annual Conference in Grapevine, Texas, September 18–19. Join oncology professionals from across the state for education, collaboration, and conversations about improving cancer care and advancing earlier detection.

Cizzle Bio will attend the Next Generation DX Summit 2026 in Washington, DC, where Dr. Lary Robinson of Moffitt Cancer Center will present on the potential of the CIZ1B biomarker in early lung cancer detection.

Cizzle Bio will attend the BIO International Convention 2026 in San Diego. The event connects biotechnology, healthcare, and life sciences leaders from around the world.

Cizzle Bio will attend the 2026 ASCO Annual Meeting in Chicago from May 29 to June 2. The event convenes global oncology leaders to share advances in cancer research, diagnostics, and clinical innovation.

Cizzle Bio will attend Health Supernova 2026 in Austin from May 13 to 14. The event connects leaders in healthcare, biotech, and innovation to explore emerging trends and collaboration opportunities.

Cizzle Bio will attend the Ci4CC Summit 2026 in San Diego. CEO Bill Behnke will participate in a panel on the commercialization of cancer therapeutics.

Cizzle Bio will attend HOPE Summit 2026 in Dallas from May 1 to 3. The event brings together patients, survivors, and caregivers for education, support, and connection.

Cizzle Bio will attend the AACR Annual Meeting 2026 in San Diego from April 17 to 22. The meeting brings together global leaders in cancer research, translational science, and clinical innovation.

Cizzle Bio will attend Capital Factory House @ SXSW 2026 in Austin from March 12 to 16. The event connects entrepreneurs, investors, and innovators during SXSW for networking and collaboration.

Cizzle Bio will attend the GO2 For Lung Cancer Voices Summit from March 1 to 3, 2026 in Washington, DC. The summit unites the lung cancer community for education, advocacy training, and engagement with federal policymakers.

Cizzle Bio will attend the 23rd Annual Winter Lung Cancer Conference from January 23 to 25, 2026 in Miami Beach. The conference brings together oncology experts to discuss advances in lung cancer diagnostics, biomarkers, and clinical management.

Cizzle Bio will attend the ASCO Gastrointestinal Cancers Symposium on January 8 to 10, 2026 in San Francisco. This premier event brings together global oncology leaders to discuss new research, diagnostic advances, and solution-focused strategies in GI cancers.

Cizzle Bio will attend the San Antonio Breast Cancer Symposium on December 9 to 12, 2025 in San Antonio, Texas. This premier global meeting covers the latest advances in breast cancer biology, diagnostics, biomarkers, clinical trials, and translational research.